Pub. Date : 2018 May
PMID : 29997966
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib. | Crizotinib | tumor protein p53 | Homo sapiens |
| 2 | We analyze the impact of TP53 mutations on response to crizotinib in patients with ALK rearrangement NSCLC. | Crizotinib | tumor protein p53 | Homo sapiens |
| 3 | Conclusions: TP53 mutations reduce responsiveness to crizotinib and worsen prognosis in ALK rearrangement NSCLC patients. | Crizotinib | tumor protein p53 | Homo sapiens |